Ciproflox-dexameth otic susp 7.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7MWH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,226
Award facts
- Contract value 100% obligated
- $1,226.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,226.40 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on December 12, 2025, with a completion deadline of December 15, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order is issued against AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 prime vendor agreement running through December 2026 that supports military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Department of Defense and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical supplies. Through its DLA prime vendor contract, AmerisourceBergen supports customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key provider within the DLA's pharmaceutical supply chain infrastructure for military medical operations.
Quick answers
Who was awarded contract SPE2DR26F7MWH?
SPE2DR26F7MWH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F7MWH worth?
The government has obligated $1,226 on SPE2DR26F7MWH.
Is contract SPE2DR26F7MWH an order under another contract?
Yes. SPE2DR26F7MWH is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MWH competed?
The extent of competition for SPE2DR26F7MWH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award